Cangene (FRA:YGE) Other Net Income (Loss) : €1.82 Mil (TTM As of Oct. 2013)

View and export this data going back to . Start your Free Trial

What is Cangene Other Net Income (Loss)?

Cangene's Other Net Income (Loss) for the three months ended in Oct. 2013 was €0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Oct. 2013 was €1.82 Mil.

Cangene's quarterly Other Net Income (Loss) increased from Apr. 2013 (€-5.46 Mil) to Jul. 2013 (€7.28 Mil) but then declined from Jul. 2013 (€7.28 Mil) to Oct. 2013 (€0.00 Mil).

Cangene's annual Other Net Income (Loss) declined from Jul. 2011 (€0.00 Mil) to Jul. 2012 (€-0.00 Mil) but then increased from Jul. 2012 (€-0.00 Mil) to Jul. 2013 (€0.00 Mil).

Cangene Other Net Income (Loss) Historical Data

The historical data trend for Cangene's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cangene Other Net Income (Loss) Chart

Cangene Annual Data

Trend

Jul04

Jul05

Jul06

Jul07

Jul08

Jul09

Jul10

Jul11

Jul12

Jul13

Other Net Income (Loss)

Get a 7-Day Free Trial

Cangene Quarterly Data
	Jan09	Apr09	Jul09	Oct09	Jan10	Apr10	Jul10	Oct10	Jan11	Apr11	Jul11	Oct11	Jan12	Apr12	Jul12	Oct12	Jan13	Apr13	Jul13	Oct13
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-5.46	7.28	-

Cangene Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Oct. 2013 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.82 Mil.

Cangene Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Cangene's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Cangene (FRA:YGE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cangene Corporation (FRA:YGE) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.cangene.com

Cangene Corporation is a fully integrated developer and manufacturer of immune therapeutics, primarily targeting infectious disease, hematology, transplantation and biodefense applications. The company manages its business and evaluate performance based on two operating segments: biopharmaceutical operations and contract services. Revenues are generated from product sales, and contract manufacturing and contract-R&D services.

Cangene (FRA:YGE) Headlines

No Headlines